Lebanon vs South Africa: Share of E. coli infections resistant to cephalosporins
Lebanon
37.2%
in 2022
South Africa
30.0%
in 2022
Lebanon rank
22nd
South Africa rank
24th
Share of E. coli infections resistant to cephalosporins over time
- Lebanon
- South Africa
How they compare
Lebanon currently reports 37.2% against 30.0% in South Africa, a difference of 7.2%.
That makes Lebanon's figure about 1.2 times South Africa's.
Across all 5 years both countries report, Lebanon has been ahead every year.
Lebanon ranks 22nd and South Africa ranks 24th of 46 countries.
Lebanon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.9% | 30.6% | 22.3% | Lebanon |
| 2020s | 47.9% | 28.6% | 19.2% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Lebanon or South Africa?
- Lebanon, at 37.2% against 30.0% in South Africa as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Lebanon and South Africa?
- 7.2%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and South Africa?
- 5 years are reported by both, from 2018 to 2022.
- How do Lebanon and South Africa rank globally for share of e. coli infections resistant to cephalosporins?
- Lebanon ranks 22nd and South Africa ranks 24th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).